{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:16:04Z","timestamp":1793826964604,"version":"4.6.1"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hand-foot syndrome (HFS) and oral mucositis (OM) are common adverse events during cancer chemotherapy and can significantly decrease patients\u2019 quality of life and chemotherapy adaptation, however, prevention strategies of these complications yet to be established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients with stages I\u2013III breast cancer, who had surgery and needed pegylated liposomal doxorubicin (PLD)-based adjuvant chemotherapy were screened, recruited and randomly assigned to receive either probiotics or placebo (three capsules, twice\/day) treatment during the course of chemotherapy from November 2019 to August 2020. The incidence and severity of PLD related HFS and OM, and patients\u2019 quality of life were assessed. Their plasma biomarkers, metabolites and fecal microbiota compositions were measured. And the results were further verified in animal experiments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Probiotics supplement during PLD treatment significantly decreased the incidence and the severity of HFS and OM (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;\u00a00.001), improved patients\u2019 life quality (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;\u00a00.001), increased the relative abundance of intestinal <jats:italic toggle=\"yes\">Enterococcus<\/jats:italic> (<jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.025) and mitigated the changes of seven plasma metabolites. Among these metabolites, the changes of p-Mentha-1,8-dien-7-ol (MDO) (<jats:italic toggle=\"yes\">B<\/jats:italic> =\u00a0\u2212\u00a00.441, <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.02) and L-arginine (<jats:italic toggle=\"yes\">B<\/jats:italic> =\u00a0\u2212\u00a00.586, <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.002) were negatively correlated with the occurrence of severe HFS and OM. MDO can partly reproduce the preventive effects of probiotics on PLD-related skin cell proliferating inhibition, DNA damage, and local inflammation in rats.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Probiotics supplement during PLD-based chemotherapy prevents the incidence and severity of HFS and OM, which may be associated with modulating plasma metabolites including the MDO.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000002147","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T19:01:23Z","timestamp":1734980483000},"page":"2018-2030","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Probiotics prevent pegylated liposomal doxorubicin-associated hand-foot syndrome and oral mucositis of breast cancer patients following surgery and chemotherapy: a randomized placebo-controlled trial"],"prefix":"10.1097","volume":"111","author":[{"given":"Zhang","family":"Juan","sequence":"first","affiliation":[{"name":"Department of Anesthesiology"},{"name":"Department of Breast Surgery, Tangshan People\u2019s Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Experimental Medicine"},{"name":"Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yongping","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"},{"name":"Department of Breast Surgery, Tangshan People\u2019s Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Tangshan People\u2019s Hospital, Tangshan, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"},{"name":"Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"},{"name":"Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"},{"name":"Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Plastic and Burns Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, Guangdong, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"},{"name":"Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2]]},"reference":[{"key":"R1-20250224","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","article-title":"Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management","volume":"71","author":"Miller","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250224","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250224","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(19)30163-9","article-title":"Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study","volume":"20","author":"Wilson","year":"2019","journal-title":"Lancet Oncol"},{"key":"R4-20250224","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/annonc\/mdl477","article-title":"Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (\u2018hand-foot\u2019 syndrome)","volume":"18","author":"Lorusso","year":"2007","journal-title":"Ann Oncol"},{"key":"R5-20250224","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/14740338.2016.1238067","article-title":"Incidence and implications of chemotherapy related hand-foot syndrome","volume":"15","author":"Nikolaou","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"R6-20250224","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejca.2005.12.011","article-title":"A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)","volume":"42","author":"Coleman","year":"2006","journal-title":"Eur J Cancer"},{"key":"R7-20250224","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00002820-200304000-00011","article-title":"Current Canadian experience with capecitabine: partnering with patients to optimize therapy","volume":"26","author":"Gerbrecht","year":"2003","journal-title":"Cancer Nursing"},{"key":"R8-20250224","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000258880","article-title":"Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib","volume":"77","author":"Lipworth","year":"2009","journal-title":"Oncology"},{"key":"R9-20250224","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","article-title":"Updated clinical practice guidelines for the prevention and treatment of mucositis","volume":"109","author":"Keefe","year":"2007","journal-title":"Cancer"},{"key":"R10-20250224","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2004.02.019","article-title":"The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma","volume":"93","author":"Molpus","year":"2004","journal-title":"Gynecologic Oncol"},{"key":"R11-20250224","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2010.29.1807","article-title":"Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study","volume":"28","author":"Kang","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R12-20250224","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2004.05.027","article-title":"Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies","volume":"94","author":"Drake","year":"2004","journal-title":"Gynecologic Oncol"},{"key":"R13-20250224","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejca.2008.01.028","article-title":"Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts","volume":"44","author":"von Moos","year":"2008","journal-title":"Eur J Cancer"},{"key":"R14-20250224","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat Neurosci"},{"key":"R15-20250224","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pharmtox-010919-023628","article-title":"Microbiota-gut-brain axis: new therapeutic opportunities","volume":"60","author":"Long-Smith","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R16-20250224","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nature Med"},{"key":"R17-20250224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrc.2017.120","article-title":"Tumour microenvironment: microbes matter","volume":"18","author":"Dart","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R18-20250224","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/d41586-018-05208-8","article-title":"How gut microbes are joining the fight against cancer","volume":"557","author":"Guglielmi","year":"2018","journal-title":"Nature"},{"key":"R19-20250224","doi-asserted-by":"crossref","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"R20-20250224","doi-asserted-by":"crossref","first-page":"8063647","DOI":"10.1155\/2018\/8063647","article-title":"Immunomodulatory effects of probiotics on cytokine profiles","volume":"2018","author":"Azad","year":"2018","journal-title":"Biomed Res Int"},{"key":"R21-20250224","doi-asserted-by":"crossref","first-page":"578386","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body","volume":"12","author":"Cristofori","year":"2021","journal-title":"Front Immunol"},{"key":"R22-20250224","doi-asserted-by":"crossref","first-page":"107988","DOI":"10.1016\/j.pharmthera.2021.107988","article-title":"Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: tales of a vicious cycle","volume":"231","author":"Chidambaram","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R23-20250224","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjd.18659","article-title":"Changing our microbiome: probiotics in dermatology","volume":"182","author":"Yu","year":"2020","journal-title":"Br J Dermatol"},{"key":"R24-20250224","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/1534735418794885","article-title":"Adjunctive treatments for the prevention of chemotherapy- and radiotherapy-induced mucositis","volume":"17","author":"Thomsen","year":"2018","journal-title":"Integr Cancer Ther"},{"key":"R25-20250224","doi-asserted-by":"crossref","first-page":"13268","DOI":"10.3390\/ijms232113268","article-title":"Preventive effect of probiotics on oral mucositis induced by cancer treatment: a systematic review and meta-analysis","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R26-20250224","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R27-20250224","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","article-title":"Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy","volume":"164","author":"Chrysostomou","year":"2023","journal-title":"Gastroenterology"},{"key":"R28-20250224","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-022-01273-9","article-title":"Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies","volume":"15","author":"Lu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R29-20250224","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"key":"R30-20250224","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol Rev"},{"key":"R31-20250224","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2021.11.006","article-title":"Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial","volume":"161","author":"Juan","year":"2022","journal-title":"Eur J Cancer"},{"key":"R32-20250224","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ejca.2011.06.010","article-title":"Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study","volume":"48","author":"Sharma","year":"2012","journal-title":"Eur J Cancer"},{"key":"R33-20250224","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cncr.31907","article-title":"A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma","volume":"125","author":"Jiang","year":"2019","journal-title":"Cancer"},{"key":"R34-20250224","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00006199-200503000-00007","article-title":"The Consolidated Standards of Reporting Trials (CONSORT): guidelines for reporting randomized trials","volume":"54","author":"Bennett","year":"2005","journal-title":"Nurs Res"},{"key":"R35-20250224","first-page":"471","article-title":"Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China (2024 edition)","volume":"46","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R36-20250224","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00128071-200001040-00004","article-title":"Antineoplastic therapy-induced palmar plantar erythrodysesthesia (\u2018hand-foot\u2019) syndrome. Incidence, recognition and management","volume":"1","author":"Nagore","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"R37-20250224","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2019.10.031","article-title":"Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer","volume":"125","author":"Mierzynska","year":"2020","journal-title":"Eur J Cancer"},{"key":"R38-20250224","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00253-015-7039-6","article-title":"Denitrifying sulfide removal process on high-salinity wastewaters in the presence of Halomonas sp","volume":"100","author":"Liu","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"R39-20250224","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jn\/nxx027","article-title":"Blueberry supplementation influences the gut microbiota, inflammation, and insulin resistance in high-fat-diet-fed rats","volume":"148","author":"Lee","year":"2018","journal-title":"J Nutr"},{"key":"R40-20250224","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40168-021-01059-0","article-title":"Identifying biases and their potential solutions in human microbiome studies","volume":"9","author":"Nearing","year":"2021","journal-title":"Microbiome"},{"key":"R41-20250224","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"R42-20250224","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"R43-20250224","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2021.07.006","article-title":"The pharmacokinetics of PEGylated liposomal doxorubicin are not significantly affected by sex in rats or humans, but may be affected by immune dysfunction","volume":"337","author":"Subasic","year":"2021","journal-title":"J Control Release"},{"key":"R44-20250224","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3322\/caac.21157","article-title":"Oral complications of cancer and cancer therapy: from cancer treatment to survivorship","volume":"62","author":"Epstein","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R45-20250224","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9931","article-title":"Separating host and microbiome contributions to drug pharmacokinetics and toxicity","volume":"363","author":"Zimmermann","year":"2019","journal-title":"Science"},{"key":"R46-20250224","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"R47-20250224","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2147\/IJN.S280187","article-title":"Reactive oxygen species-mediated inflammation and apoptosis in hand-foot syndrome induced by pegylated liposomal doxorubicin","volume":"16","author":"Hu","year":"2021","journal-title":"Int J Nanomed"},{"key":"R48-20250224","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","article-title":"Combinatorial, additive and dose-dependent drug-microbiome associations","volume":"600","author":"Forslund","year":"2021","journal-title":"Nature"},{"key":"R49-20250224","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41380-020-0744-2","article-title":"The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression","volume":"26","author":"Zheng","year":"2021","journal-title":"Mol Psychiatry"},{"key":"R50-20250224","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.3390\/ijms19123905","article-title":"Intranasal perillyl alcohol for glioma therapy: molecular mechanisms and clinical development","volume":"19","author":"Chen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R51-20250224","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ddr.21436","article-title":"Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson\u2019s disease model.","volume":"79","author":"Anis","year":"2018","journal-title":"Drug Dev Res"},{"key":"R52-20250224","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/cells12050793","article-title":"Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"R53-20250224","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R54-20250224","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/apt.14203","article-title":"Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease","volume":"46","author":"Derwa","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R55-20250224","doi-asserted-by":"crossref","first-page":"150621","DOI":"10.1016\/j.bbrc.2024.150621","article-title":"The interplay of metabolic and epigenetic players in disease development","volume":"734","author":"Chakraborty","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"R56-20250224","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MOL.0000000000000550","article-title":"Metabolism: the road to inflammation and atherosclerosis","volume":"29","author":"Ali","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"R57-20250224","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.joen.2005.10.049","article-title":"Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment","volume":"32","author":"Stuart","year":"2006","journal-title":"J Endodontics"},{"key":"R58-20250224","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymben.2013.05.004","article-title":"Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production","volume":"19","author":"Alonso-Gutierrez","year":"2013","journal-title":"Metab Eng"},{"key":"R59-20250224","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00253-016-7337-7","article-title":"Biotechnological production of limonene in microorganisms","volume":"100","author":"Jongedijk","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"R60-20250224","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R61-20250224","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jjco\/hyl109","article-title":"Phase 1 clinical study of pegylated liposomal doxorubicin (JNS002) in Japanese patients with solid tumors","volume":"36","author":"Fujisaka","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"R62-20250224","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1470-2045(21)00216-3","article-title":"Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study","volume":"22","author":"Pujade-Lauraine","year":"2021","journal-title":"Lancet Oncol"},{"key":"R63-20250224","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/jog.13334","article-title":"Skin-mucous membrane disorder and therapeutic effect of pegylated liposomal doxorubicin in recurrent ovarian cancer","volume":"43","author":"Yamada","year":"2017","journal-title":"J Obstet Gynaecol Res"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:16:09Z","timestamp":1740399369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002147","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"2024-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}